Metagenomi (MGX) Competitors $4.05 +0.19 (+4.92%) (As of 12/20/2024 05:40 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends MGX vs. IGMS, SIGA, KALV, KRRO, AURA, TSHA, RGNX, SANA, GHRS, and ALMSShould you be buying Metagenomi stock or one of its competitors? The main competitors of Metagenomi include IGM Biosciences (IGMS), SIGA Technologies (SIGA), KalVista Pharmaceuticals (KALV), Korro Bio (KRRO), Aura Biosciences (AURA), Taysha Gene Therapies (TSHA), REGENXBIO (RGNX), Sana Biotechnology (SANA), GH Research (GHRS), and Alumis (ALMS). These companies are all part of the "pharmaceutical products" industry. Metagenomi vs. IGM Biosciences SIGA Technologies KalVista Pharmaceuticals Korro Bio Aura Biosciences Taysha Gene Therapies REGENXBIO Sana Biotechnology GH Research Alumis Metagenomi (NASDAQ:MGX) and IGM Biosciences (NASDAQ:IGMS) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, institutional ownership, earnings, valuation, media sentiment, profitability, analyst recommendations, community ranking and risk. Does the media prefer MGX or IGMS? In the previous week, IGM Biosciences had 6 more articles in the media than Metagenomi. MarketBeat recorded 6 mentions for IGM Biosciences and 0 mentions for Metagenomi. IGM Biosciences' average media sentiment score of 0.39 beat Metagenomi's score of 0.00 indicating that IGM Biosciences is being referred to more favorably in the news media. Company Overall Sentiment Metagenomi Neutral IGM Biosciences Neutral Do institutionals and insiders hold more shares of MGX or IGMS? 42.8% of IGM Biosciences shares are owned by institutional investors. 57.0% of IGM Biosciences shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Is MGX or IGMS more profitable? Metagenomi has a net margin of -134.27% compared to IGM Biosciences' net margin of -7,534.03%. Metagenomi's return on equity of -43.23% beat IGM Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Metagenomi-134.27% -43.23% -18.86% IGM Biosciences -7,534.03%-155.42%-61.04% Does the MarketBeat Community prefer MGX or IGMS? IGM Biosciences received 53 more outperform votes than Metagenomi when rated by MarketBeat users. However, 95.00% of users gave Metagenomi an outperform vote while only 50.70% of users gave IGM Biosciences an outperform vote. CompanyUnderperformOutperformMetagenomiOutperform Votes1995.00% Underperform Votes15.00%IGM BiosciencesOutperform Votes7250.70% Underperform Votes7049.30% Do analysts recommend MGX or IGMS? Metagenomi presently has a consensus price target of $16.67, indicating a potential upside of 311.52%. IGM Biosciences has a consensus price target of $17.75, indicating a potential upside of 157.25%. Given Metagenomi's stronger consensus rating and higher probable upside, analysts clearly believe Metagenomi is more favorable than IGM Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Metagenomi 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86IGM Biosciences 1 Sell rating(s) 2 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has higher earnings and valuation, MGX or IGMS? Metagenomi has higher revenue and earnings than IGM Biosciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMetagenomi$55.08M2.75-$68.25MN/AN/AIGM Biosciences$2.92M140.61-$246.42M-$3.64-1.90 SummaryMetagenomi beats IGM Biosciences on 9 of the 15 factors compared between the two stocks. Ad Insiders ExposedHas Trump Finally Gone Too Far?Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.Register For The Webinar To Discover Get Metagenomi News Delivered to You Automatically Sign up to receive the latest news and ratings for MGX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart MGX vs. The Competition Export to ExcelMetricMetagenomiBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$151.57M$2.94B$5.10B$9.07BDividend YieldN/A1.90%4.90%4.21%P/E RatioN/A45.9491.0817.15Price / Sales2.75411.851,113.51116.81Price / CashN/A182.1042.2637.86Price / BookN/A3.894.784.78Net Income-$68.25M-$42.21M$119.77M$225.60M7 Day Performance25.00%-2.14%-1.87%-1.23%1 Month Performance123.14%4.21%11.46%3.07%1 Year PerformanceN/A18.39%30.53%16.48% Metagenomi Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)MGXMetagenomi2.1336 of 5 stars$4.05+4.9%$16.67+311.5%N/A$151.57M$55.08M0.00236High Trading VolumeIGMSIGM Biosciences4.5517 of 5 stars$7.64+6.6%$17.75+132.3%-12.2%$454.31M$2.92M-2.11190News CoverageSIGASIGA Technologies1.6095 of 5 stars$6.30+1.9%N/A+4.6%$449.82M$139.92M5.1540Positive NewsGap DownKALVKalVista Pharmaceuticals3.9512 of 5 stars$9.06+4.3%$24.00+164.9%-24.0%$447.75MN/A-2.39150Analyst ForecastKRROKorro Bio1.2664 of 5 stars$47.29+0.9%$142.17+200.6%-21.8%$443.11M$14.07M0.0070AURAAura Biosciences2.4687 of 5 stars$8.75+4.0%$23.00+162.9%-3.1%$437.07MN/A-4.8650News CoverageTSHATaysha Gene Therapies3.6226 of 5 stars$2.11+1.9%$6.63+214.0%+30.3%$432.42M$15.45M3.29180RGNXREGENXBIO4.5991 of 5 stars$8.72+5.3%$35.27+304.5%-58.4%$431.99M$90.24M-1.65344SANASana Biotechnology2.0915 of 5 stars$1.92+1.6%$13.50+603.1%-59.8%$428.68MN/A-1.35328GHRSGH Research1.1295 of 5 stars$8.10+4.7%$35.67+340.3%+28.8%$421.43MN/A-9.8010ALMSAlumisN/A$8.71+3.8%$26.83+208.1%N/A$411.30MN/A0.00N/AAnalyst ForecastLockup ExpirationNews CoveragePositive News Related Companies and Tools Related Companies IGM Biosciences Competitors SIGA Technologies Competitors KalVista Pharmaceuticals Competitors Korro Bio Competitors Aura Biosciences Competitors Taysha Gene Therapies Competitors REGENXBIO Competitors Sana Biotechnology Competitors GH Research Competitors Alumis Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:MGX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Metagenomi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Metagenomi With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
